BeiGene, Ltd.·4

Jun 19, 4:18 PM ET

su Jingshyh S 4

4 · BeiGene, Ltd. · Filed Jun 19, 2020

Insider Transaction Report

Form 4
Period: 2020-06-17
Transactions
  • Award

    Share Option (Right to Buy)

    2020-06-17+45,38345,383 total
    Exercise: $13.42Exp: 2030-06-16Ordinary Shares (45,383 underlying)
Footnotes (2)
  • [F1]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares.
  • [F2]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.

Documents

1 file
  • 4
    wf-form4_159259789928473.xmlPrimary

    FORM 4